AUPHAurinia Pharmaceuticals Inc.
- Market cap
- $2.24B
- as of 2026-10-23
- Latest close
- $16.86
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-02-22
Dashed line = amended filing (Form 4/A)
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Robertson Stephen P.Chief Legal Officer | Sep 10 | Sep 11 | S | 11,939 | $15.95 | Sale −$190,427 | 588,848 | No | Form 4 |
| Robertson Stephen P.Chief Legal Officer | Aug 21 | Aug 25 | S | 20,975 | $16.97 | Sale −$355,946 | 600,787 | No | Form 4 |
| Nova Tina Susan | Jun 4 | Jun 8 | A · derivative | 23,931 | $15.67 | $374,999 | 23,931 | No | Form 4 |
| Johnson Craig A | Jun 4 | Jun 8 | A · derivative | 23,931 | $15.67 | $374,999 | 23,931 | No | Form 4 |
| Bailey Jeffrey Allen | Jun 4 | Jun 8 | A · derivative | 23,931 | $15.67 | $374,999 | 23,931 | No | Form 4 |
| Goetz Kathleen | Jun 4 | Jun 8 | A · derivative | 23,931 | $15.67 | $374,999 | 23,931 | No | Form 4 |
| Tang KevinChief Executive Officer | Jun 2 | Jun 2 | P | 206,005 | $15.28 | Purchase +$3,147,756 | 13,044,106 | No | Form 4 |
| Tang KevinChief Executive Officer | Jun 2 | Jun 2 | J · derivative | 10,000 | $1.65 | $16,500 | 10,000 | No | Form 4 |
| Tang KevinChief Executive Officer | Jun 1 | Jun 2 | P | 343,521 | $15.28 | Purchase +$5,249,001 | 12,838,002 | No | Form 4 |
| Tang KevinChief Executive Officer | Jun 1 | Jun 2 | P | 99 | $15.34 | Purchase +$1,519 | 12,838,101 | No | Form 4 |
| Tang KevinChief Executive Officer | May 29 | Jun 2 | P | 2,299 | $15.35 | Purchase +$35,290 | 12,231,799 | No | Form 4 |
| Tang KevinChief Executive Officer | May 29 | Jun 2 | P | 262,682 | $15.31 | Purchase +$4,021,661 | 12,494,481 | No | Form 4 |
| Hearne Michael SChief Financial Officer | May 18 | May 20 | A | 116,144 | $0.00 | $0 | 116,144 | No | Form 4 |
| Hearne Michael SChief Financial Officer | May 18 | May 20 | A · derivative | 70,230 | $15.28 | $1,073,114 | 70,230 | No | Form 4 |
| Robertson Stephen P.Chief Legal Officer | May 18 | May 20 | A | 115,541 | $0.00 | $0 | 621,402 | No | Form 4 |
| Cole RyanChief Operating Officer | May 18 | May 20 | A | 116,144 | $0.00 | $0 | 116,144 | No | Form 4 |
| Cole RyanChief Operating Officer | May 18 | May 20 | A · derivative | 70,230 | $15.28 | $1,073,114 | 70,230 | No | Form 4 |
| Keenan GregSVP, Chief Medical Officer | Mar 6 | Mar 10 | F | 8,069 | $14.32 | $115,548 | 154,449 | No | Form 4 |
| Tang Kevin | Mar 3 | Mar 3 | P | 184,208 | $14.22 | Purchase +$2,619,438 | 12,229,500 | No | Form 4 |
| Tang Kevin | Mar 2 | Mar 3 | P | 83,561 | $14.33 | Purchase +$1,197,429 | 11,929,500 | No | Form 4 |
| Tang Kevin | Mar 2 | Mar 3 | P | 115,792 | $14.21 | Purchase +$1,645,404 | 12,045,292 | No | Form 4 |
| Robertson Stephen P.EVP, General Counsel | Mar 2 | Mar 3 | F | 36,525 | $14.21 | $519,020 | 505,861 | No | Form 4 |
| Greenleaf PeterChief Executive Officer | Mar 2 | Mar 3 | F | 100,890 | $14.21 | $1,433,647 | 1,840,379 | No | Form 4 |
| Donley Matthew MaxwellChief Operating Officer | Mar 2 | Mar 3 | F | 40,761 | $14.21 | $579,214 | 680,299 | No | Form 4 |
| Miller Joseph MChief Financial Officer | Mar 2 | Mar 3 | F | 37,511 | $14.21 | $533,031 | 576,421 | No | Form 4 |
| Tang Kevin | Feb 27 | Mar 3 | P | 300,000 | $13.90 | Purchase +$4,170,000 | 11,629,500 | No | Form 4 |
| Tang Kevin | Feb 27 | Mar 3 | P | 214,839 | $14.12 | Purchase +$3,033,527 | 11,844,339 | No | Form 4 |
| Tang Kevin | Feb 27 | Mar 3 | P | 1,600 | $14.38 | Purchase +$23,008 | 11,845,939 | No | Form 4 |
| Robertson Stephen P.EVP, General Counsel | Feb 27 | Mar 3 | A | 59,090 | $0.00 | $0 | 542,386 | No | Form 4 |
| Robertson Stephen P.EVP, General Counsel | Feb 27 | Mar 3 | A · derivative | 98,813 | $13.97 | $1,380,418 | 98,813 | No | Form 4 |
| Keenan GregSVP, Chief Medical Officer | Feb 27 | Mar 3 | A | 40,586 | $0.00 | $0 | 162,518 | No | Form 4 |
| Keenan GregSVP, Chief Medical Officer | Feb 27 | Mar 3 | A · derivative | 67,870 | $13.97 | $948,144 | 67,870 | No | Form 4 |
| Greenleaf PeterChief Executive Officer | Feb 27 | Mar 3 | A | 196,403 | $0.00 | $0 | 1,941,269 | No | Form 4 |
| Greenleaf PeterChief Executive Officer | Feb 27 | Mar 3 | A · derivative | 328,424 | $13.97 | $4,588,083 | 328,424 | No | Form 4 |
| Donley Matthew MaxwellChief Operating Officer | Feb 27 | Mar 3 | A | 58,160 | $0.00 | $0 | 721,060 | No | Form 4 |
| Donley Matthew MaxwellChief Operating Officer | Feb 27 | Mar 3 | A · derivative | 97,256 | $13.97 | $1,358,666 | 97,256 | No | Form 4 |
| Miller Joseph MChief Financial Officer | Feb 27 | Mar 3 | A | 57,229 | $0.00 | $0 | 613,932 | No | Form 4 |
| Miller Joseph MChief Financial Officer | Feb 27 | Mar 3 | A · derivative | 95,700 | $13.97 | $1,336,929 | 95,700 | No | Form 4 |
| Greenleaf PeterChief Executive Officer | Feb 20 | Feb 23 | F | 100,171 | $14.40 | $1,442,462 | 1,744,866 | No | Form 4 |
| Donley Matthew MaxwellChief Operating Officer | Feb 20 | Feb 23 | F | 32,901 | $14.40 | $473,774 | 662,900 | No | Form 4 |
| Miller Joseph MChief Financial Officer | Feb 20 | Feb 23 | F | 32,424 | $14.40 | $466,906 | 556,703 | No | Form 4 |
| Robertson Stephen P.EVP, General Counsel | Feb 20 | Feb 23 | F | 34,638 | $14.40 | $498,787 | 483,296 | No | Form 4 |
| Keenan GregSVP, Chief Medical Officer | Feb 2 | Feb 3 | F | 11,552 | $14.53 | $167,851 | 121,932 | No | Form 4 |
| Greenleaf PeterChief Executive Officer | Jan 2 | Jan 5 | A | 165,384 | $0.00 | $0 | 1,954,329 | No | Form 4 |
| Greenleaf PeterChief Executive Officer | Jan 2 | Jan 5 | F | 113,169 | $15.95 | $1,805,046 | 1,845,037 | No | Form 4 |
| Miller Joseph MChief Financial Officer | Jan 2 | Jan 5 | A | 49,038 | $0.00 | $0 | 626,399 | No | Form 4 |
| Miller Joseph MChief Financial Officer | Jan 2 | Jan 5 | F | 40,161 | $15.95 | $640,568 | 589,127 | No | Form 4 |
| Donley Matthew MaxwellChief Operating Officer | Jan 2 | Jan 5 | A | 54,166 | $0.00 | $0 | 734,631 | No | Form 4 |
| Donley Matthew MaxwellChief Operating Officer | Jan 2 | Jan 5 | F | 42,787 | $15.95 | $682,453 | 695,801 | No | Form 4 |
| Robertson Stephen P.EVP, General Counsel | Jan 2 | Jan 5 | A | 48,558 | $0.00 | $0 | 557,434 | No | Form 4 |
| Robertson Stephen P.EVP, General Counsel | Jan 2 | Jan 5 | F | 40,385 | $15.95 | $644,141 | 517,934 | No | Form 4 |
| Johnson Craig A | Nov 21, 2025 | Nov 24, 2025 | F | 6,039 | $15.68 | $94,692 | 14,592 | No | Form 4 |
| Bailey Jeffrey Allen | Nov 21, 2025 | Nov 24, 2025 | F | 2,716 | $15.68 | $42,587 | 22,775 | No | Form 4 |
| Tang Kevin | Aug 5, 2025 | Aug 5, 2025 | P | 200,000 | $11.68 | Purchase +$2,336,000 | 11,329,500 | No | Form 4 |
| Tang Kevin | Aug 4, 2025 | Aug 5, 2025 | P | 100,000 | $11.34 | Purchase +$1,134,000 | 11,129,500 | No | Form 4 |
| Tang Kevin | Aug 1, 2025 | Aug 5, 2025 | P | 1,000,000 | $10.12 | Purchase +$10,120,000 | 11,029,500 | No | Form 4 |
| Keenan GregChief Medical Officer | Aug 1, 2025 | Aug 5, 2025 | S | 20,000 | $10.50 | Sale −$210,000 | 133,484 | No | Form 4 |
| Bailey Jeffrey Allen | May 16, 2025 | May 16, 2025 | A · derivative | 37,485 | $8.15 | $305,503 | 37,485 | No | Form 4 |
| Goetz Kathleen | May 16, 2025 | May 16, 2025 | A · derivative | 63,724 | $8.15 | $519,351 | 63,724 | No | Form 4 |
| Johnson Craig A | May 16, 2025 | May 16, 2025 | A · derivative | 37,485 | $8.15 | $305,503 | 37,485 | No | Form 4 |
| Nova Tina Susan | May 16, 2025 | May 16, 2025 | A · derivative | 63,724 | $8.15 | $519,351 | 63,724 | No | Form 4 |
| Keenan GregChief Medical Officer | Mar 7, 2025 | Mar 7, 2025 | S | 8,305 | $8.23 | Sale −$68,350 | 153,484 | No | Form 4 |
| Tang Kevin | Mar 4, 2025 | Mar 4, 2025 | P | 148,038 | $8.00 | Purchase +$1,184,304 | 9,429,500 | No | Form 4 |
| Tang Kevin | Mar 4, 2025 | Mar 4, 2025 | P | 500,000 | $7.92 | Purchase +$3,960,000 | 9,929,500 | No | Form 4 |
| Tang Kevin | Mar 4, 2025 | Mar 4, 2025 | P | 100,000 | $8.09 | Purchase +$809,000 | 10,029,500 | No | Form 4 |
| Donley Matthew MaxwellChief Operating Officer | Mar 4, 2025 | Mar 4, 2025 | S | 58,991 | $7.92 | Sale −$467,209 | 680,465 | No | Form 4 |
| Robertson Stephen P.EVP, General Counsel | Mar 4, 2025 | Mar 4, 2025 | S | 57,607 | $7.92 | Sale −$456,247 | 509,276 | No | Form 4 |
| Miller Joseph MChief Financial Officer | Mar 4, 2025 | Mar 4, 2025 | S | 56,154 | $7.92 | Sale −$444,740 | 577,361 | No | Form 4 |
| Greenleaf PeterChief Executive Officer | Mar 4, 2025 | Mar 4, 2025 | S | 164,947 | $7.92 | Sale −$1,306,380 | 1,788,945 | No | Form 4 |
| Tang Kevin | Mar 3, 2025 | Mar 4, 2025 | P | 100,720 | $7.97 | Purchase +$802,738 | 8,929,500 | No | Form 4 |
| Tang Kevin | Mar 3, 2025 | Mar 4, 2025 | P | 351,962 | $8.02 | Purchase +$2,822,735 | 9,281,462 | No | Form 4 |
| Donley Matthew MaxwellChief Operating Officer | Mar 3, 2025 | Mar 4, 2025 | A | 135,567 | $0.00 | $0 | 805,358 | No | Form 4 |
| Donley Matthew MaxwellChief Operating Officer | Mar 3, 2025 | Mar 4, 2025 | S | 65,902 | $8.00 | Sale −$527,216 | 739,456 | No | Form 4 |
| Robertson Stephen P.EVP, General Counsel | Mar 3, 2025 | Mar 4, 2025 | A | 102,406 | $0.00 | $0 | 631,755 | No | Form 4 |
| Robertson Stephen P.EVP, General Counsel | Mar 3, 2025 | Mar 4, 2025 | S | 64,872 | $8.00 | Sale −$518,976 | 566,883 | No | Form 4 |
| Miller Joseph MChief Financial Officer | Mar 3, 2025 | Mar 4, 2025 | A | 114,711 | $0.00 | $0 | 695,374 | No | Form 4 |
| Miller Joseph MChief Financial Officer | Mar 3, 2025 | Mar 4, 2025 | S | 61,859 | $8.00 | Sale −$494,872 | 633,515 | No | Form 4 |
| Keenan GregChief Medical Officer | Mar 3, 2025 | Mar 4, 2025 | S | 12,239 | $8.00 | Sale −$97,912 | 161,789 | No | Form 4 |
| Greenleaf PeterChief Executive Officer | Mar 3, 2025 | Mar 4, 2025 | A | 333,705 | $0.00 | $0 | 2,149,485 | No | Form 4 |
| Greenleaf PeterChief Executive Officer | Mar 3, 2025 | Mar 4, 2025 | S | 195,593 | $8.00 | Sale −$1,564,744 | 1,953,892 | No | Form 4 |
| Tang Kevin | Feb 28, 2025 | Mar 4, 2025 | P | 399,280 | $7.85 | Purchase +$3,134,348 | 8,828,780 | No | Form 4 |
| Donley Matthew MaxwellChief Operating Officer | Feb 28, 2025 | Mar 4, 2025 | A | 82,781 | $0.00 | $0 | 669,791 | No | Form 4 |
| Donley Matthew MaxwellChief Operating Officer | Feb 28, 2025 | Mar 4, 2025 | A · derivative | 126,416 | $7.55 | $954,441 | 126,416 | No | Form 4 |
| Robertson Stephen P.EVP, General Counsel | Feb 28, 2025 | Mar 4, 2025 | A | 84,106 | $0.00 | $0 | 529,349 | No | Form 4 |
| Robertson Stephen P.EVP, General Counsel | Feb 28, 2025 | Mar 4, 2025 | A · derivative | 128,438 | $7.55 | $969,707 | 128,438 | No | Form 4 |
| Miller Joseph MChief Financial Officer | Feb 28, 2025 | Mar 4, 2025 | A | 81,457 | $0.00 | $0 | 580,663 | No | Form 4 |
| Miller Joseph MChief Financial Officer | Feb 28, 2025 | Mar 4, 2025 | A · derivative | 124,393 | $7.55 | $939,167 | 124,393 | No | Form 4 |
| Keenan GregChief Medical Officer | Feb 28, 2025 | Mar 4, 2025 | A | 62,583 | $0.00 | $0 | 174,028 | No | Form 4 |
| Keenan GregChief Medical Officer | Feb 28, 2025 | Mar 4, 2025 | A · derivative | 95,570 | $7.55 | $721,554 | 95,570 | No | Form 4 |
| Greenleaf PeterChief Executive Officer | Feb 28, 2025 | Mar 4, 2025 | A | 290,728 | $0.00 | $0 | 1,815,780 | No | Form 4 |
| Greenleaf PeterChief Executive Officer | Feb 28, 2025 | Mar 4, 2025 | A · derivative | 443,973 | $7.55 | $3,351,996 | 443,973 | No | Form 4 |
| Tang Kevin | Dec 9, 2024 | Dec 9, 2024 | P | 500,000 | $9.09 | Purchase +$4,545,000 | 8,429,500 | No | Form 4 |
| Tang Kevin | Dec 6, 2024 | Dec 9, 2024 | P | 400,000 | $9.01 | Purchase +$3,604,000 | 7,929,500 | No | Form 4 |
| Tang Kevin | Dec 5, 2024 | Dec 9, 2024 | P | 300,000 | $8.91 | Purchase +$2,673,000 | 7,529,500 | No | Form 4 |
| Jayne David R.W. | Nov 21, 2024 | Nov 25, 2024 | A | 12,135 | $0.00 | $0 | 56,499 | No | Form 4 |
| Jayne David R.W. | Nov 21, 2024 | Nov 25, 2024 | A · derivative | 18,641 | $8.24 | $153,602 | 18,641 | No | Form 4 |
| Bailey Jeffrey Allen | Nov 21, 2024 | Nov 25, 2024 | A | 12,135 | $0.00 | $0 | 25,491 | No | Form 4 |
| Bailey Jeffrey Allen | Nov 21, 2024 | Nov 25, 2024 | A · derivative | 18,641 | $8.24 | $153,602 | 18,641 | No | Form 4 |
| Johnson Craig A | Nov 21, 2024 | Nov 25, 2024 | A | 20,631 | $0.00 | $0 | 20,631 | No | Form 4 |
| Johnson Craig A | Nov 21, 2024 | Nov 25, 2024 | A · derivative | 31,688 | $8.24 | $261,109 | 31,688 | No | Form 4 |
| Leversage Jill | Nov 21, 2024 | Nov 25, 2024 | A | 12,135 | $0.00 | $0 | 25,053 | No | Form 4 |
| Leversage Jill | Nov 21, 2024 | Nov 25, 2024 | A · derivative | 18,641 | $8.24 | $153,602 | 18,641 | No | Form 4 |
| Smith Karen L. | Nov 21, 2024 | Nov 25, 2024 | A | 12,135 | $0.00 | $0 | 24,807 | No | Form 4 |
| Smith Karen L. | Nov 21, 2024 | Nov 25, 2024 | A · derivative | 18,641 | $8.24 | $153,602 | 18,641 | No | Form 4 |
| Smith Karen L. | Nov 11, 2024 | Nov 12, 2024 | S | 5,241 | $8.43 | Sale −$44,182 | 12,672 | No | Form 4 |
| Bailey Jeffrey Allen | Nov 11, 2024 | Nov 12, 2024 | S | 4,557 | $8.43 | Sale −$38,416 | 13,356 | No | Form 4 |
| Smith Karen L. | Nov 8, 2024 | Nov 12, 2024 | M | 17,913 | not reported | not reported | 17,913 | No | Form 4 |
| Smith Karen L. | Nov 8, 2024 | Nov 12, 2024 | M · derivative | 17,913 | $0.00 | $0 | not reported | No | Form 4 |
| Bailey Jeffrey Allen | Nov 8, 2024 | Nov 12, 2024 | M | 17,913 | not reported | not reported | 17,913 | No | Form 4 |
| Bailey Jeffrey Allen | Nov 8, 2024 | Nov 12, 2024 | M · derivative | 17,913 | $0.00 | $0 | not reported | No | Form 4 |
| Habig Scott MichaelChief Commercial Officer | Aug 6, 2024 | Aug 8, 2024 | S | 18,249 | $5.31 | Sale −$96,902 | 456,338 | No | Form 4 |
| MacKay-Dunn R. Hector | May 21, 2024 | May 22, 2024 | S | 5,630 | $5.74 | Sale −$32,316 | 18,595 | No | Form 4 |
| Leversage Jill | May 21, 2024 | May 22, 2024 | S | 5,610 | $5.74 | Sale −$32,201 | 12,918 | No | Form 4 |
| Jayne David R.W. | May 21, 2024 | May 22, 2024 | S | 4,946 | $5.74 | Sale −$28,390 | 44,364 | No | Form 4 |
| Billen Daniel | May 21, 2024 | May 22, 2024 | S | 5,252 | $5.74 | Sale −$30,146 | 28,141 | No | Form 4 |
| Balakrishnan Brinda | May 21, 2024 | May 22, 2024 | S | 520 | $5.74 | Sale −$2,985 | 17,523 | No | Form 4 |
| Robertson Stephen P.EVP, General Counsel | Mar 6, 2024 | Mar 7, 2024 | S | 57,745 | $5.60 | Sale −$323,372 | 443,824 | No | Form 4 |
| Habig Scott MichaelChief Commercial Officer | Mar 6, 2024 | Mar 7, 2024 | S | 17,777 | $5.60 | Sale −$99,551 | 474,587 | No | Form 4 |
| Donley Matthew MaxwellEVP, Ops & Strategy | Mar 6, 2024 | Mar 7, 2024 | S | 40,665 | $5.51 | Sale −$224,064 | 584,072 | No | Form 4 |
| Miller Joseph MChief Financial Officer | Mar 6, 2024 | Mar 7, 2024 | S | 34,811 | $5.60 | Sale −$194,942 | 495,928 | No | Form 4 |
| Greenleaf PeterChief Executive Officer | Mar 6, 2024 | Mar 7, 2024 | S | 126,981 | $5.60 | Sale −$711,094 | 1,522,114 | No | Form 4 |
| Knappertz VolkerEVP, Research and Development | Feb 27, 2024 | Feb 29, 2024 | S | 4,930 | $6.10 | Sale −$30,073 | 319,128 | No | Form 4 |
| Greenleaf PeterChief Executive Officer | Feb 20, 2024 | Feb 22, 2024 | A | 661,538 | $0.00 | $0 | 1,649,095 | No | Form 4 |
| Miller Joseph MChief Financial Officer | Feb 20, 2024 | Feb 22, 2024 | A | 196,153 | $0.00 | $0 | 530,739 | No | Form 4 |
| Robertson Stephen P.EVP, General Counsel | Feb 20, 2024 | Feb 22, 2024 | A | 194,230 | $0.00 | $0 | 501,569 | No | Form 4 |
| Donley Matthew MaxwellEVP, Ops & Strategy | Feb 20, 2024 | Feb 22, 2024 | A | 216,666 | $0.00 | $0 | 624,737 | No | Form 4 |
| Habig Scott MichaelChief Commercial Officer | Feb 20, 2024 | Feb 22, 2024 | A | 195,512 | $0.00 | $0 | 508,231 | No | Form 4 |
| Habig Scott MichaelChief Commercial Officer | Feb 20, 2024 | Feb 22, 2024 | S | 15,867 | $5.48 | Sale −$86,951 | 492,364 | No | Form 4 |
| Knappertz VolkerEVP, Research and Development | Feb 20, 2024 | Feb 22, 2024 | S | 25,146 | $5.48 | Sale −$137,800 | 324,058 | No | Form 4 |
| Greenleaf PeterChief Executive Officer | Mar 2, 2023 | Feb 22, 20244/A | S | 33,047 | $8.78 | Sale −$290,153 | 982,671 | No | Form 4/A |
| Miller Joseph MChief Financial Officer | Mar 2, 2023 | Feb 22, 20244/A | S | 11,398 | $8.78 | Sale −$100,074 | 331,112 | No | Form 4/A |
| Robertson Stephen P.EVP, General Counsel | Mar 2, 2023 | Feb 22, 20244/A | S | 19,644 | $8.78 | Sale −$172,474 | 303,122 | No | Form 4/A |